6 results
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... Tuberculosis #MDRTB #management ... #pharmacology #dosing ... #idsa #drugs #steps
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... HIV-AIDS Treating LTBI ... HIV-infected persons with clinical ... Tuberculosis #TB #IDSA ... #management #opportunistic
Induction agents used in anesthesia play a key role in the eventual sedation of the patient,
of the patient, leading ... #clinical #management ... Amidate (etomidate) dosing ... reference.medscape.com/drug ... Effects, Dosages, Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI ... inhibitors • Injection drug ... killed - rest LTBI ... characteristic features Clinical ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI ... inhibitors • Injection drug ... killed - rest LTBI ... characteristic features Clinical ... TB #Diagnosis #Management
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... disease based on clinical ... to Table 5 for dosing ... #Prevention #Treatment ... #management #opportunistic